Psilocybin for Enhanced Analgesia in Chronic nEuropathic PAIN

Clinical trial NCT06731335 · RECRUITING

Trial details

NCT number: NCT06731335
Sponsor: Unity Health Toronto
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Neuropathic Pain Pain Management

Start date: 2025-03-05
Primary completion: 2026-08-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.